B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

Panelists discuss the primary access challenges in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) treatment, including financial barriers and health care system limitations, and how ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

The following is a summary of “Expansion of multiple CD4+ T cell lineages in lymphocytic variant hypereosinophilic syndrome,” ...

Zanubrutinib shows durable efficacy in CLL/SLL with 17p deletions, according to 5-year SEQUOIA trial data.

Making CAR T Vision a reality will require the coming together of a complex ecosystem of partners, each with their own unique role to play. To learn more about CAR T Vision, review the roadmap report ...

I’ve lived with large granular lymphocytic leukemia for 16 years and have learned to spend my energy wisely, embrace ...

EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia: Amsterdam, The Netherlands Monday, May 26, 2025, 16:00 Hr ...

The autologous immunotherapy consists of the patient’s own T cells engineered to express a chimeric antigen receptor that ...